
    
      To provide both the French National Authority for Health and the French Economic Committee
      for Health Products requested information on patient-reported outcomes for the IN.PACT™
      Admiral™ Drug-Coated Balloon. Patients will be followed using routine clinical practice and
      the collection of two validated instruments: EuroQOL EQ-5D Quality of Life questionnaire and
      the Walking Impairment Questionnaire (WIQ).
    
  